Torc2 Limited

Torc2 Ltd was formed to develop an innovative re-usable splint system that helps orthopedic clinicians in their work with patients requiring leg and arm manipulation treatments to correct limb abnormalities.

These include those suffering from conditions such as Cerebral Palsy, Talipes and leg amputees. Currently, the solution to any changes required, due to growth in children or the need to manipulate limbs, is to either estimate the modifications needed and remove the device from the patient, or to take another cast of the limb in order to re-model a new one. The device or cast is then sent away to a specialist orthotics technician with the clinicians instructions, a process that can take up to 6 weeks and the re-adjusted or new device generally has a 1 in 3 chance of being incorrect.

The provisionally patented solution proposed makes use of a highly specific thermoplastics compound together with state of the art flexible heaters and thin film packaging. The new products combine the need for close fitting support with the ability to easily make alterations in order to accommodate changes as determined by the supervising clinician since they will be able to soften, reshape directly onto the patient, and re-set the strategic parts in minutes in an outpatient environment. In some cases, for example prosthetic sockets, it is expected that patients could be trained to reshape the limb end contact at home in order to achieve maximum comfort and eliminate pressure points.

The Innovation Networks funding was required to design and build a number of working prototypes for evaluation and testing by key
members of the Coventry and Warwickshire medical fraternity who had helped by defining their clinical needs and by their enthusiastic support for the idea.

This work was undertaken in conjunction with the RDM Group, based in Coventry, who had the necessary expertise to assist in the design and prototyping of the initial proof of concept splints and knowledge of the regulatory requirements for medical device approval.Major benefits arising from the introduction of these products include a device which is more comfortable to use, easier to
reshape and has potential cost savings within the NHS by virtue of the immediacy of the solution.

The device is mainly constructed from recyclable materials and can potentially be sterilized and reused.